|

68Ga-TATE-RGD Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Peking Union Medical College Hospital1

Indications

  • Iodine-resistant Thyroid Cancer1
  • NETs1
  • Meningioma1
  • Cancer1

Other1 trial

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.